Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Robson

Showing results (71-80 of 218) with videos related to

Pageof 22
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
BRCA mutations in women with ductal carcinoma in situKaren Lisa Smith, Muriel Adank, Noah Kauff, et al.
Plos One|October 4, 2022
Raising the bar for patient experience during care transitions in Canada: A repeated cross-sectional survey evaluating a patient-oriented discharge summary at Ontario hospitalsKaren Okrainec, Audrey Chaput, Valeria E Rac, et al.
Breast Cancer Research and Treatment|August 23, 2023
Electro-acupuncture versus battle field auricular acupuncture in breast cancer survivors with chronic musculoskeletal pain: subgroup analysis of a randomized clinical trialTing Bao, W Iris Zhi, Raymond E Baser, et al.
Oncogene|October 10, 2002
Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancersWilliam B Archey, Kristen A McEachern, Mark Robson, et al.
Familial Cancer|June 14, 2005
The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindredsRina Siddiqui, Kenan Onel, Flavia Facio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Germline EGFR T790M mutation found in multiple members of a familial cohortHelena A Yu, Maria E Arcila, Megan Harlan Fleischut, et al.
Annals of Surgical Oncology|May 21, 2013
Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancerZachary S Zumsteg, Monica Morrow, Brittany Arnold, et al.
Fertility and Sterility|April 26, 2020
Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiencyKutluk H Oktay, Giuliano Bedoschi, Shari B Goldfarb, et al.
Science Translational Medicine|February 15, 2013
Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humansShiny Titus, Fang Li, Robert Stobezki, et al.
Archives of Pathology & Laboratory Medicine|October 25, 2019
Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Updates on HER2 Assessment in Breast Cancer With Equivocal HER2 Immunohistochemistry Results With Focus on Cases With <i>HER2</i>/CEP17 Ratio <2.0 and Average <i>HER2</i> Copy Number ≥4.0 and <6.0Raza S Hoda, Edi Brogi, Jin Xu, et al.
Pageof 22

Showing results (71-80 of 218) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
BRCA mutations in women with ductal carcinoma in situKaren Lisa Smith, Muriel Adank, Noah Kauff, et al.
Plos One|October 4, 2022
Raising the bar for patient experience during care transitions in Canada: A repeated cross-sectional survey evaluating a patient-oriented discharge summary at Ontario hospitalsKaren Okrainec, Audrey Chaput, Valeria E Rac, et al.
Breast Cancer Research and Treatment|August 23, 2023
Electro-acupuncture versus battle field auricular acupuncture in breast cancer survivors with chronic musculoskeletal pain: subgroup analysis of a randomized clinical trialTing Bao, W Iris Zhi, Raymond E Baser, et al.
Oncogene|October 10, 2002
Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancersWilliam B Archey, Kristen A McEachern, Mark Robson, et al.
Familial Cancer|June 14, 2005
The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindredsRina Siddiqui, Kenan Onel, Flavia Facio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Germline EGFR T790M mutation found in multiple members of a familial cohortHelena A Yu, Maria E Arcila, Megan Harlan Fleischut, et al.
Annals of Surgical Oncology|May 21, 2013
Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancerZachary S Zumsteg, Monica Morrow, Brittany Arnold, et al.
Fertility and Sterility|April 26, 2020
Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiencyKutluk H Oktay, Giuliano Bedoschi, Shari B Goldfarb, et al.
Science Translational Medicine|February 15, 2013
Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humansShiny Titus, Fang Li, Robert Stobezki, et al.
Archives of Pathology & Laboratory Medicine|October 25, 2019
Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Updates on HER2 Assessment in Breast Cancer With Equivocal HER2 Immunohistochemistry Results With Focus on Cases With <i>HER2</i>/CEP17 Ratio <2.0 and Average <i>HER2</i> Copy Number ≥4.0 and <6.0Raza S Hoda, Edi Brogi, Jin Xu, et al.
Pageof 22